A retrospective study investigating safety of oral Voriconazole by assessing dose and weight dependent toxicity in patients with hematologic malignancy and allogeneic stem cell transplant .
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Voriconazole (Primary)
- Indications Aspergillosis; Candidiasis; Fusariosis; Mycoses
- Focus Adverse reactions
- 28 Dec 2015 New trial record